PEPSICO INC. DL-,0166/ US7134481081 /
30.05.2024 8:00:42 | Изменение -1.82 | Объем сделки | Бид21:55:46 | Предложение21:55:46 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
157.54EUR | -1.14% | 0 Оборот: 0.00 |
157.52Величина цены спроса: 200 | 157.78Величина цены предложения: 200 | 217.23 млрдEUR | - | - |
GlobeNewswire
22:10
Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirements
GlobeNewswire
22:10
Kimco Realty® Management to Present at Nareit’s REITweek: 2024 Investor Conference
GlobeNewswire
22:05
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:05
IndyCar Driver Marcus Armstrong to Represent Root Insurance at Detroit Grand Prix
GlobeNewswire
22:05
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of P...
GlobeNewswire
22:05
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedr...
GlobeNewswire
22:05
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
GlobeNewswire
22:05
Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Stu...
GlobeNewswire
22:05
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
GlobeNewswire
22:05
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:05
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
GlobeNewswire
22:05
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница